| actinomycin D | doxorubicin | vincristine | HG-U133A |
---|---|---|---|---|
Total number of probesets in target list | 3309 | 1019 | 134 | 22215 |
Total number of probesets with annotated biological process | 2158 | 702 | 87 | 13704 |
Physiological process | Â | Â | Â | Â |
   Cell growth and/or maintenance | 827*** | 262* | 40* | 4701 |
Cell proliferation | 367*** | 123*** | 14 | 1576 |
Cell cycle | 290*** | 87*** | 10 | 1085 |
   Death | 151*** | 39 | 5 | 682 |
   Metabolism | 1507*** | 429 | 50 | 8247 |
Regulation of biological process | Â | Â | Â | Â |
   Regulation of programmed cell death | 87*** | 22 | 2 | 400 |
Anti-apoptosis | 41*** | 5 | 2 | 152 |
Positive regulation of apoptosis | 50* | 10 | 0 | 231 |
   Regulation of signal transduction | 49* | 13 | 3 | 242 |
I-κB kinase/NF-κB cascade | 29* | 7 | 2 | 123 |
   Regulation of metabolism | 509*** | 121 | 22* | 2398 |
Protein biosynthesis | 54*** | 6 | 1 | 156 |
Nucleobase, nucleoside, nucleotide synthesis | 455*** | 111 | 21* | 2232 |
Negative regulation of nucleobase, nucleoside, nucleotide and nucleid acid metabolism | 49*** | 8 | 2 | 180 |
DNA metabolism | 15** | 1 | 0 | 50 |